X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/immunoforge-doses-first-patient-in-phase-2-clinical-trial-of-froniglutide-for-dermatomyositispolymyositis-301958194.html
https://www.prnewswire.com/news-releases/immunoforge-expands-drug-development-licensing-agreement-with-duke-university-301828243.html
https://www.prnewswire.com/news-releases/immunoforge-inc-receives-us-fda-odd-for-treatment-of-polymyositis-301384587.html